Dr. Mahsa Javid, MD

Dr. Javid practices at Jewish Hospital and St Mary's Healthcare - HOPD in Louisville, Kentucky.

Dr. Javid's NPI, 1831508050, was assigned on August 13, 2014. Dr. Javid holds Kentucky license 56425.

Dr. Javid's primary practice is Jewish Hospital and St Mary's Healthcare - HOPD, at 200 Abraham Flexner Way, Louisville, KY 40202.

Dr. Javid's primary practice is Jewish Hospital and St Mary's Healthcare - HOPD in Louisville, Kentucky. Dr. Javid is also affiliated with UofL Health - Jewish Hospital. The medical group on file is UofL Physicians, Radiology. Dmand AI also links Dr. Javid to 2 more hospitals, 3 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Javid practices, 7 sites in all. Vendor and product names are available with a free account.

Surgery is Dr. Javid's primary specialty in the NPI Registry, under taxonomy code 208600000X. Dmand AI has Dr. Javid's licenses on file in 2 states: Kentucky and South Carolina.

CMS data shows 93 Medicare services from Dr. Javid across 4 procedure codes in 2024, for 53 Medicare patients. Medicare paid $15,854 for them.

CMS counts 53 Medicare patients who saw Dr. Javid in 2024. The largest group is 65 to 74, with 37 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.84, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Javid's median patient age at 67, with 78% women.

In 2024, Dr. Javid wrote 19 Medicare Part D claims for 12 patients. 74% of them were for generic drugs. CMS names the drug for 12 of them, across 1 drug with 11 or more claims each, at $102 in total drug cost. In 2020, CMS named 34 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 79 out of 100 for Dr. Javid for performance year 2024, reported as part of a group. Dr. Javid accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 15 papers to Dr. Javid, published from 2010 to 2025. 2016 was the busiest year, with 3. The most frequent topics are Adenoma, Cell Proliferation and Immunohistochemistry. Dr. Javid has published most often in AACE Clin Case Rep. Dr. Javid's most frequent co-authors are Tobias Je Carling, MD, PhD, Glenda Grace Callender, MD and Courtney Elizabeth Gibson, MD.

CMS Open Payments shows 17 general payments to Dr. Javid from 4 drug and device companies from 2018 to 2025. Speaker and faculty fees make up the largest share, 83% of the total. Corcept Therapeutics paid the most, $8,631.